Active Clinical Trials

March 21, 2025
March 21, 2025
Categories

Amended Trial: David Sher Gives an Update on the EA3211 Trial for Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck

The changes significantly broaden eligibility and clarify key details in this phase 3 trial exploring whether adding radiation therapy to standard immunotherapy will improve survival in patients with stable disease after initial treatment
Do you like it?
0 Read more
October 17, 2024
Woman talking with doctor
October 17, 2024
Categories

Amended Trial: Robert Ferris Gives an Update on the EA3132 Trial for Patients with Head and Neck Cancer

The changes aim to alleviate scheduling difficulties during the randomization step, and they introduce the new tumor test for this phase 2 trial testing radiotherapy with or without chemotherapy
Do you like it?
0 Read more
September 17, 2024
PrECOG logo
September 17, 2024
Categories

Now Enrolling: PrE1702 Real-World Data Study for Patients with EGFR-Mutated Non-Small Cell Lung Cancer Not Enrolled in Clinical Trials

This innovative real-world data study is developing an infrastructure to conduct a study comparing outcomes in patients with EGFR-mutated NSCLC receiving osimertinib with or without chemotherapy and not enrolled in a clinical trial
Do you like it?
0 Read more
July 3, 2024
July 3, 2024
Categories

Amended Trial: Nataliya Uboha Gives an Update on the EA2183 Trial for Patients with Esophageal and Gastric Adenocarcinoma

The changes broaden eligibility for patients and permit more therapeutic options once enrolled in this randomized phase 3 trial, which explores the addition of radiotherapy to the usual treatment (chemotherapy) in people with esophagus and stomach cancer with limited spread
Do you like it?
0 Read more
123456789